Report overview
Quantitative detection of HBV-DNA is mainly used to evaluate the level of virus replication in HBV-infected patients, and is an important indicator for the selection of antiviral treatment indications and the judgment of efficacy. During antiviral therapy, obtaining a sustained virological response can significantly control the progression of cirrhosis and reduce the risk of HCC.
This report contains market size and forecasts of Hepatitis B Virus Nucleic Acid Detection Kit in global, including the following market information:
Global Hepatitis B Virus Nucleic Acid Detection Kit Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Hepatitis B Virus Nucleic Acid Detection Kit Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Hepatitis B Virus Nucleic Acid Detection Kit companies in 2021 (%)
The global Hepatitis B Virus Nucleic Acid Detection Kit market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Ultra-sensitive Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hepatitis B Virus Nucleic Acid Detection Kit include Shanghai Rendu Biotechnology, Roche, Abbott, Shengxiang Biotechnology, Jiangsu Mole Biotechnology, Hangzhou Bioer Technology, Guangzhou Daan Gene, Jiangsu Shuoshi Biotechnology Co., Ltd. and cayudi bio, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hepatitis B Virus Nucleic Acid Detection Kit manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis B Virus Nucleic Acid Detection Kit Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hepatitis B Virus Nucleic Acid Detection Kit Market Segment Percentages, by Type, 2021 (%)
Ultra-sensitive
High sensitivity
General Sensitivity
Global Hepatitis B Virus Nucleic Acid Detection Kit Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hepatitis B Virus Nucleic Acid Detection Kit Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Hepatitis B Virus Nucleic Acid Detection Kit Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hepatitis B Virus Nucleic Acid Detection Kit Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis B Virus Nucleic Acid Detection Kit revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Hepatitis B Virus Nucleic Acid Detection Kit revenues share in global market, 2021 (%)
Key companies Hepatitis B Virus Nucleic Acid Detection Kit sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Hepatitis B Virus Nucleic Acid Detection Kit sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Shanghai Rendu Biotechnology
Roche
Abbott
Shengxiang Biotechnology
Jiangsu Mole Biotechnology
Hangzhou Bioer Technology
Guangzhou Daan Gene
Jiangsu Shuoshi Biotechnology Co., Ltd.
cayudi bio
Fosun Pharma
Huamei Bio
Xiamen Ampley
Hangzhou Aikang
Hangzhou Bosai
